论文信息 - A Phase II Trial of R-FM (Rituximab, Fludarabine and Mitoxantrone) Chemotherapy Followed by Yttrium 90 ( 90 Y) Ibritumomab Tiuxetan ( 90 Y-IT) for Untreated Follicular Lymphoma (FL) Patients. - 字舞流文

A Phase II Trial of R-FM (Rituximab, Fludarabine and Mitoxantrone) Chemotherapy Followed by Yttrium 90 ( 90 Y) Ibritumomab Tiuxetan ( 90 Y-IT) for Untreated Follicular Lymphoma (FL) Patients.

M. Baccarani | S. Fanti | P. Zinzani | E. Derenzini | A. Pulsoni | A. Broccoli | V. Stefoni | M. Tani | A. D. Renzo | C. Pellegrini | L. Gandolfi | M. Fina